Alyeska Investment Group
TEVA icon

Alyeska Investment Group’s Teva Pharmaceuticals TEVA Stock Holding History

Alyeska Investment Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$166M Buy
5,519,030
+1,983,068
+56% +$63.8M 0.47% 44
2025
Q4 		$110M Sell
3,535,962
-2,440,073
-41% -$60.1M 0.31% 82
2025
Q3 		$121M Buy
5,976,035
+3,545,577
+146% +$62.3M 0.37% 67
2025
Q2 		$40.7M Sell
2,430,458
-795,155
-25% -$12.8M 0.14% 181
2025
Q1 		$49.6M Sell
3,225,613
-415,779
-11% -$7.43M 0.2% 144
2024
Q4 		$80.3M Buy
3,641,392
+16,392
+0.5% +$298K 0.3% 81
2024
Q3 		$65.3M Sell
3,625,000
-203,871
-5% -$3.57M 0.33% 102
2024
Q2 		$62.2M Sell
3,828,871
-2,516,937
-40% -$38.8M 0.36% 94
2024
Q1 		$89.5M Buy
6,345,808
+886,499
+16% +$11.2M 0.55% 50
2023
Q4 		$57M Sell
5,459,309
-1,003,267
-16% -$9.37M 0.38% 82
2023
Q3 		$65.9M Buy
6,462,576
+4,962,576
+331% +$46.2M 0.45% 71
2023
Q2 		$11.3M Buy
1,500,000
+700,000
+88% +$5.68M 0.08% 254
2023
Q1 		$7.08M Buy
+800,000
New +$7.91M 0.06% 278
2016
Q2 		– Sell
-334,318
Closed -$17.9M – 498
2016
Q1 		$17.9M Sell
334,318
-1,090,927
-77% -$64M 0.16% 190
2015
Q4 		$93.6M Buy
1,425,245
+1,400,730
+5,714% +$86.6M 0.99% 12
2015
Q3 		$1.38M Buy
+24,515
New +$1.59M 0.02% 364
2015
Q2 		– Sell
-579,879
Closed -$36.1M – 571
2015
Q1 		$36.1M Buy
+579,879
New +$33.7M 0.5% 51
2014
Q3 		– Sell
-231,640
Closed -$12.1M – 452
2014
Q2 		$12.1M Sell
231,640
-143,360
-38% -$7.33M 0.27% 129
2014
Q1 		$19.8M Buy
+375,000
New +$17.3M 0.54% 52

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Alyeska Investment Group's TEVA Position: Q1 2026 in Review

Alyeska Investment Group increased its Teva Pharmaceuticals (TEVA) stake by 56% in Q1 2026, buying an estimated $63.8M and bringing the position to 5,519,030 shares worth $166M. The position accounts for 0.47% of the portfolio, ranked #44.

Alyeska Investment Group first reported a position in TEVA in Q1 2014 and has held it in 19 quarters since. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Alyeska Investment Group held 5,519,030 shares of Teva Pharmaceuticals worth $166M as of Q1 2026.
  • Alyeska Investment Group bought 1,983,068 Teva Pharmaceuticals shares in Q1 2026, an estimated $63.8M.
  • Teva Pharmaceuticals made up 0.47% of Alyeska Investment Group's portfolio in Q1 2026, its #44 holding.
  • Alyeska Investment Group first reported a position in Teva Pharmaceuticals in Q1 2014 and has held it in 19 quarters since.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.